Pharmafile Logo
Pharmafocus logo
Advanced Search
china_block_001_takeda

Takeda’s dengue vaccine surpasses Sanofi’s in P2 trial

November 7, 2017
Manufacturing and Production, Sales and Marketing Sanofi, Takeda, biotech, drugs, pharma, pharmaceutical

Sanofi spent more than $1.5 billion and two decades to develop the first ever vaccine for dengue fever, only a …

News
addyi-prescription

Valeant backs away from female libido pill

November 7, 2017
Manufacturing and Production, Sales and Marketing Addyi, Valeant, biotech, drugs, pharma, pharmaceutical

Only two years ago, Valeant was so keen to get involved with a pill reported to increase the female libido …

News
window-2387518_960_720

Clinical trial transparency: Letting the light in

November 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, clinical trial transparency, clinical trials, drugs, pharma, pharmaceutical

Transparency is one of those words for which the exact meaning has become clouded by murkier connotations. The chances are …

Feature
merckkgaahq

Merck KGaA posts promising osteoarthritis data

November 6, 2017
Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA’s share price is 7% down over the course of the year – a year that, on the pharmaceutical …

News
eye_2

Valeant begins long comeback trail with FDA approval

November 6, 2017
Sales and Marketing Valeant, Vyzulta, biotech, drugs, pharma, pharmaceutical

Valeant has had precious little to be happy about over the last few years, it’s bounced from one piece of …

News
bacteria-1959386_960_720

Gut bacteria may be key to efficacy of immunotherapies

November 6, 2017
Research and Development, Sales and Marketing biotech, drugs, immunotherapy, pharma, pharmaceutical

Why immunotherapies are successful in some individuals and not in others is a matter of huge importance to both patients …

News
smartphone-1957740_960_720

NHS to offer GP appointments via smartphone

November 6, 2017
Medical Communications, Sales and Marketing GP at hand, NHS, biotech, drugs, pharma, pharmaceutical

It has been announced that I trial will begin in London offering the public GP consultations through their smartphone. The …

News
novartis_hq_day

Novartis aims for CAR-T double-approval in Europe

November 6, 2017
Sales and Marketing CAR-T, Gilead, Juno, Novartis, biotech, drugs, pharma, pharmaceutical

Just last week Novartis revealed it had applied to the FDA for a new indication in diffuse large B-cell lymphoma …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug, pharma, pharmaceuticals, top ten

As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …

News
dr-patrick-vallance-gsk

GSK’s R&D head to move on after shift in focus

November 3, 2017
Medical Communications GSK, biotech, drugs, pharma, pharmaceutical

There has been a raft of changes at senior levels of GSK since Emma Walmsley took over the role from …

News
andrew_witty_gsk_new

Witty to lead way in fast-tracking medicine through UK system

November 3, 2017
Medical Communications AAR, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical

The UK government has announced its response to the Accelerated Access Review that was published last year, with former GSK …

News
gsk_boronia_australia

GSK’s experimental multiple myeloma scores Breakthrough designation with FDA

November 3, 2017
Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, GSK, GlaxoSmithKline, multiple myeloma, pharma

GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a monotherapy in …

News

Teva’s woes continue, as shares sink to 17-year low on Q3 results

November 2, 2017
Medical Communications Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Spare a thought for Kare Schultz, he agreed to take on the position of CEO at Teva at the start …

News
online

Tissue Regenix promotes new CEO from within

November 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, tissue regenix

Just over two weeks ago, Tissue Regenix announced that its long-standing CEO, Antony Odell, would be leaving the company. It …

Appointment

FDA issues warnings in crackdown on baseless cannabis miracle cures

November 2, 2017
Research and Development, Sales and Marketing FDA, cannabidiol, cannabis, pharma

The FDA has issued a warning over cannabis-based therapies which promise the ability to cure cancer, asserting that such treatments …

News

Sanofi Q3 results disappoint due to waning diabetes sales

November 2, 2017
Sales and Marketing Lantus, Sanofi, diabetes, pharma

Sanofi readjusted its 2017 financial expectations after its third-quarter results came in lower than projected. The company revealed that net …

News
pregnant-2640994_960_720

New test could determine womens’ risk of miscarriage or premature birth

November 2, 2017
Research and Development biotech, drugs, pharma, pharmaceutical, pregnancy

Scientists in the US have reported findings suggesting that certain molecules in the blood are strongly associated with complications during …

News

Allergan ready to take a loss by selling Teva shares

November 2, 2017
Sales and Marketing Allergan, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Allergan sold its generic business to Teva back in August 2016 for a sum of $33 billion and 100 million …

News

Novartis reveals the data behind its showdown with Gilead

November 1, 2017
Research and Development CAR-T, Gilead, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical

Only yesterday it was revealed that Novartis had applied to the FDA in the same indication that Gilead’s treatment is …

News
csm_tk12_17_rupert_sandbrink_kl_fb0c325239

Topas Therapeutics brings in new CMO

November 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Topas Therapeutics, biotech, drugs, pharma, pharmaceutical

Topas Therapeutics, a German company focused on developing novel therapeutics to treat immune-mediated and autoimmune diseases, announced that it has …

Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026